학술논문
High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study
Document Type
Article
Author
Source
In: Rheumatology International . (Rheumatology International, 1 December 2020, 40(12):2015-2021)
Subject
Language
English
ISSN
1437160X
01728172
01728172